Clinical trials recruiting for Psoriasis
233
Recruiting trials
46
US states with sites
54
Countries
17%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Deucravacitinib | 11 |
| Guselkumab | 11 |
| Methotrexate | 9 |
| Ustekinumab | 6 |
| Bimekizumab | 5 |
| Risankizumab | 5 |
| Ixekizumab | 4 |
| Zasocitinib | 4 |
| Adalimumab | 3 |
| Apremilast | 3 |
| Secukinumab | 3 |
| Tirzepatide | 3 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 33 |
| Florida | 27 |
| Ohio | 26 |
| Texas | 25 |
| New York | 20 |
| Pennsylvania | 18 |
| Arizona | 16 |
| Massachusetts | 16 |
| North Carolina | 16 |
| Georgia | 14 |
| Illinois | 14 |
| Maryland | 14 |
Top cities
Houston, Texas 14New York, New York 12Fountain Valley, California 11Philadelphia, Pennsylvania 11Phoenix, Arizona 11Tampa, Florida 11Miami, Florida 10San Diego, California 9Birmingham, Alabama 8Dallas, Texas 8
Self-screener
Recruiting trials
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
- A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
- A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
- A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
- A Phase 2 Study of HB0017 in Psoriasis Patients
- A Phase 3 Clinical Study of QL2106 Injection
- A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
- A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
- A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
- A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
- A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis
- A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
- A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
- A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
- A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
- A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
- A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
- A Study of Picankibart in Patients With Active Psoriatic Arthritis
- A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
- A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
- A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- A Study to Assess Deucravacitinib Safety in Pregnancy
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
- A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
- A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
- A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
- APACHE Cohort (A Psoriatic Arthritis CoHort)
- AYLo - AutoimmunitY and Loss of y
- Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
- An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
- An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
- Anti Inflammatory Diet With Physical Therapy on Psoriasis
- Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis
- Biobank for Inflammatory Chronic Diseases and Osteoporosis
- COMFI - a COMbined Fatigue Intervention
- Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient
- Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Chinese Psoriasis Real World Evidence Research
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
- Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
- Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
- Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
- Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
- Correction of Psoriatic T Cell Signatures by Deucravacitinib
- Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
- Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Cytokine Expression in Psoriasis Patients With and Without Joint Involvement
- Deployment o the Multidisciplinary Prospective Cohort Imminent
- Determinants of Chronic Inflammatory Skin Disease Trajectories
- Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
- Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
- Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- Dietary Approach to Mild-to-moderate Psoriasis
- Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
- Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
- Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
- Duobrii in Combination With Biologics
- Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
- Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients
- Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
- Effect of Semaglutide in Patients With Psoriasis and Obesity
- Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial
- Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
Related conditions
Trials recruiting for Psoriasis often also study these conditions. Each links to its own recruiting-trial list.
Psoriatic arthritis 45Rheumatoid arthritis 314Plaque Psoriasis 25Lupus 332Eczema 196Psoriatic Arthritis (PsA 18Psoriasis (PsO) 17Crohn's disease 328Atopic dermatitis 126Arthritis, Psoriatic 13
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Psoriasis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.